Eledon Pharmaceuticals (ELDN) Interest Coverage Ratio (QoQ) (2015 - 2025)
Eledon Pharmaceuticals (ELDN) Interest Coverage Ratio (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Eledon Pharmaceuticals | 5.43 Mn | -105.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13.39% |
| Jun 30, 2025 | -52.64% |
| Mar 31, 2025 | 92.21% |
| Dec 31, 2024 | -548.62% |
| Sep 30, 2024 | -66.69% |
| Jun 30, 2024 | 43.10% |
| Mar 31, 2024 | 63.73% |
| Dec 31, 2023 | -354.14% |
| Sep 30, 2023 | -29.91% |
| Jun 30, 2023 | 86.78% |
| Mar 31, 2023 | 77.88% |
| Dec 31, 2022 | -4,832.50% |
| Sep 30, 2022 | 19.93% |
| Jun 30, 2022 | 84.93% |
| Mar 31, 2022 | 32.85% |
| Dec 31, 2021 | 94.24% |
| Sep 30, 2021 | -8,961.44% |
| Jun 30, 2021 | 84.23% |
| Mar 31, 2021 | -38.96% |
| Dec 31, 2020 | 91.40% |